Indications
Onerji is indicated for the treatment of motor fluctuations in patients with advanced Parkinson's disease which are not sufficiently controlled by oral anti-Parkinson medicinal products.
Composition
- Active substance
- levodopa, carbidopa
- International name (INN)
- levodopa;carbidopa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Onerji
- Active substance
- levodopa, carbidopa
- ATC code
- N04BA02
- Group
- Nervous system
- Therapeutic area
- Parkinson Disease
- Marketing authorisation holder
- Tanabe Pharma GmbH
- Status